AB0526 CLINICAL AND ULTRASONOGRAPHIC REMISSION IN BIO-NAÏVE AND BIO-FAILURE RHEUMATOID ARTHRITIS PATIENTS AT 24-WEEK OF UPADACITINIB TREATMENT: THE UPARAREMUS REAL-LIFE STUDY
Annamaria Iagnocco(University of Turin), Caterina Baldi(University of Siena), Roberta Rosa(University of Naples Federico II), Maria Sofia Cattaruzza(Sapienza University of Rome), Gian Domenico Sebastiani(Carlo Forlanini Hospital), Bruno Frediani(University of Siena), Maria Sole Chimenti(University of Rome Tor Vergata), Marco Canzoni(Azienda Sanitaria Locale Viterbo), Arias-Díaz Antonio, Ivan Giovannini(University of Udine), Valentino Paci(Marche Polytechnic University), Chiara Scirocco, M. M. Luchetti, A. Zabotti, Bruno Laganà, Giorgio Sesti(Sapienza University of Rome), Carlo Perricone(Sapienza University of Rome), Simonetta Salemi(Sapienza University of Rome), G. Crepaldi(University of Turin)
Cited by 0
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation
|European Respiratory Journal|2005|383
Diabetes Is an Independent Predictor for Severe Osteoarthritis
|Diabetes Care|2012|334